PDS Biotechnology Corp (PDSB)
2.88
+0.24
(+9.09%)
USD |
NASDAQ |
Jun 24, 16:00
2.88
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Accounts Payable (Quarterly): 6.001M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.001M |
December 31, 2023 | 6.983M |
September 30, 2023 | 5.367M |
June 30, 2023 | 4.415M |
March 31, 2023 | 2.072M |
December 31, 2022 | 1.219M |
September 30, 2022 | 2.037M |
June 30, 2022 | 1.878M |
March 31, 2022 | 2.746M |
December 31, 2021 | 1.309M |
September 30, 2021 | 1.446M |
June 30, 2021 | 2.375M |
March 31, 2021 | 0.9506M |
December 31, 2020 | 1.415M |
September 30, 2020 | 1.560M |
June 30, 2020 | 1.092M |
March 31, 2020 | 2.557M |
December 31, 2019 | 1.198M |
September 30, 2019 | 1.489M |
Date | Value |
---|---|
June 30, 2019 | 1.853M |
March 31, 2019 | 2.665M |
December 31, 2018 | 0.3994M |
September 30, 2018 | 0.5907M |
June 30, 2018 | 1.723M |
March 31, 2018 | 2.957M |
December 31, 2017 | 4.369M |
September 30, 2017 | 2.965M |
June 30, 2017 | 4.350M |
March 31, 2017 | 2.528M |
December 31, 2016 | 3.471M |
September 30, 2016 | 1.963M |
June 30, 2016 | 2.855M |
March 31, 2016 | 2.883M |
December 31, 2015 | 2.584M |
September 30, 2015 | 2.645M |
June 30, 2015 | 1.084M |
December 31, 2014 | 2.046M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.9506M
Minimum
Mar 2021
6.983M
Maximum
Dec 2023
2.498M
Average
1.866M
Median
Accounts Payable (Quarterly) Benchmarks
Syros Pharmaceuticals Inc | 11.35M |
PAVmed Inc | 1.485M |
Perspective Therapeutics Inc | 6.027M |
Palatin Technologies Inc | 3.443M |
iBio Inc | 1.228M |